We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPL icon
3301
LG Display
LPL
$3.5B
$28K ﹤0.01%
+2,803
New +$24.1K
LQD icon
3302
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$28K ﹤0.01%
208
-225
-52% -$29.9K
MLI icon
3303
Mueller Industries
MLI
$14.6B
$28K ﹤0.01%
1,892
-7,364
-80% -$99.5K
MTRX icon
3304
Matrix Service
MTRX
$335M
$28K ﹤0.01%
3,688
-1,641
-31% -$15.4K
NOBL icon
3305
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$28K ﹤0.01%
574
-54,630
-99% -$2.58M
PI icon
3306
Impinj
PI
$5.28B
$28K ﹤0.01%
315
-1,123
-78% -$81.5K
PPBI
3307
DELISTED
Pacific Premier Bancorp
PPBI
$28K ﹤0.01%
681
-4,699
-87% -$195K
PRA
3308
DELISTED
ProAssurance
PRA
$28K ﹤0.01%
1,081
-7,825
-88% -$187K
RDWR icon
3309
Radware
RDWR
$1.23B
$28K ﹤0.01%
662
-648
-49% -$22K
RLMD icon
3310
Relmada Therapeutics
RLMD
$512M
$28K ﹤0.01%
1,227
+546
+80% +$12.1K
RUSHA icon
3311
Rush Enterprises Class A
RUSHA
$9.6B
$28K ﹤0.01%
737
-852
-54% -$29.8K
SAND
3312
DELISTED
Sandstorm Gold
SAND
$28K ﹤0.01%
4,563
-17,089
-79% -$107K
SIL icon
3313
Global X Silver Miners ETF NEW
SIL
$4.79B
$28K ﹤0.01%
775
+727
+1,515% +$27.6K
SSP icon
3314
E.W. Scripps
SSP
$320M
$28K ﹤0.01%
1,436
-3,976
-73% -$76.8K
THRM icon
3315
Gentherm
THRM
$1.35B
$28K ﹤0.01%
320
-1,181
-79% -$99.4K
WTTR icon
3316
Select Water Solutions
WTTR
$2.69B
$28K ﹤0.01%
4,585
-33,534
-88% -$208K
XERS icon
3317
Xeris Biopharma Holdings
XERS
$1.57B
$28K ﹤0.01%
9,400
+3,465
+58% +$7.48K
TBIO
3318
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$28K ﹤0.01%
144
+95
+194% +$14.8K
LKCO
3319
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$28K ﹤0.01%
193
+115
+147% +$26.1K
ENG
3320
DELISTED
ENGlobal Corp
ENG
$28K ﹤0.01%
+2,636
New +$44K
MDC
3321
DELISTED
M.D.C. Holdings, Inc.
MDC
$28K ﹤0.01%
499
-13,861
-97% -$706K
PRVB
3322
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$28K ﹤0.01%
4,945
+592
+14% +$3.76K
GLS
3323
DELISTED
Gelesis Holdings, Inc.
GLS
$28K ﹤0.01%
2,865
+2,645
+1,202% +$26.3K
CDAK
3324
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$28K ﹤0.01%
2,558
+1,952
+322% +$27.1K
ATNX
3325
DELISTED
Athenex, Inc. Common Stock
ATNX
$28K ﹤0.01%
1,029
-445
-30% -$18.8K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.